| 000 | 01328 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515080832.0 | ||
| 264 | 0 | _c20090304 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1619-7089 | ||
| 024 | 7 |
_a10.1007/s00259-007-0531-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmits, A | |
| 245 | 0 | 0 |
_aAdding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cJan 2008 |
||
| 300 |
_a65-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCarbon Radioisotopes |
| 650 | 0 | 4 |
_aGlioma _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethionine _xchemistry |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPositron-Emission Tomography |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSocieties, Medical |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aWesterberg, E | |
| 700 | 1 | _aRibom, D | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 35 _gno. 1 _gp. 65-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-007-0531-1 _zAvailable from publisher's website |
| 999 |
_c17241200 _d17241200 |
||